Given the differences in IGFBP1 in different GDM subtypes, and increasing recognition in the field that GDM is a heterogeneous condition45, our finding of persistently lower IGFBP1 levels in the second trimester of pregnancies affected by insulin-resistant GDM may have implications for GDM precision medicine46,47. Here, INS is linked to gestational diabetes.